Why did ERA.PA stock drop 20% intraday on 20 Feb 2026?

The slide followed a company plan for a €500.00 million capital increase and asset disposals after FY2025 showed a 54.00% EBITDA decline and net losses. Markets priced dilution and execution risk, triggering heavy selling and higher intraday volume.

What is Meyka AI’s outlook and grade for ERA.PA stock?

Meyka AI rates ERA.PA **60.74** out of 100 (Grade B, Suggestion: HOLD). The grade balances strong book value against weak earnings and high leverage. Grades are informational only and not financial advice.

What price targets and forecasts exist for ERA.PA stock?

Meyka AI's forecast model projects monthly €65.90, quarterly €83.78 and yearly €34.42. Scenario targets: conservative €40.00, base €50.00, bull €70.00. Forecasts are model-based projections and not guarantees.

Which metrics should investors monitor after the capital increase?

Watch diluted share count, proceeds utilisation, net debt reduction, adjusted EBITDA margin recovery and asset-sale completion. Also monitor cash per share, interest coverage and quarterly guidance updates for signs of operational stabilization.

EU Stocks

ERAMET (ERA.PA EURONEXT) -20% intraday 20 Feb 2026: capital increase raises risk

ByDanny Kontos February 20, 2026February 20, 2026

The sell-off is immediate: ERA.PA stock plunged to €48.30, down -20.03% intraday on 20 Feb 2026 after management announced a €500.00 million capital increase and asset disposals. Volume accelerated to 56,732 shares versus a 50-day average near 83,458, pushing the share well below the 50-day average of €65.02. Traders are pricing near-term dilution and a weaker 2025 earnings outlook, while investors must weigh balance-sheet relief against persistent operating losses and high leverage.